Sydney Colin Neill serves as Executive at PHARMOS CORP, where they oversee executive responsibilities. Since joining the company, Sydney Colin Neill has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 23, 2008 involved receiving (via award) 75,000 shares valued at $26.3K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 23, 2008 | PARS | $26.3K | Award | 75,000 | $0.35 | Discretionary |
Sydney Colin Neill currently holds 75,000 shares of PHARMOS CORP (PARS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sydney Colin Neill has been a net neutral trader of PARS stock. They have purchased $0 and sold $0 worth of shares.
Sydney Colin Neill's most recent insider trade was on Jan 23, 2008, when they sold 75,000 shares at $0.35 per share.
Get notified when new Form 4 filings are submitted